[go: up one dir, main page]

GB9621293D0 - Formulations containing unsaturated fatty acids - Google Patents

Formulations containing unsaturated fatty acids

Info

Publication number
GB9621293D0
GB9621293D0 GBGB9621293.1A GB9621293A GB9621293D0 GB 9621293 D0 GB9621293 D0 GB 9621293D0 GB 9621293 A GB9621293 A GB 9621293A GB 9621293 D0 GB9621293 D0 GB 9621293D0
Authority
GB
United Kingdom
Prior art keywords
fatty acids
unsaturated fatty
formulations containing
containing unsaturated
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9621293.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Priority to GBGB9621293.1A priority Critical patent/GB9621293D0/en
Publication of GB9621293D0 publication Critical patent/GB9621293D0/en
Priority to PCT/GB1997/002756 priority patent/WO1998016233A1/en
Priority to AU45679/97A priority patent/AU4567997A/en
Priority to ZA9709054A priority patent/ZA979054B/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
GBGB9621293.1A 1996-10-11 1996-10-11 Formulations containing unsaturated fatty acids Pending GB9621293D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9621293.1A GB9621293D0 (en) 1996-10-11 1996-10-11 Formulations containing unsaturated fatty acids
PCT/GB1997/002756 WO1998016233A1 (en) 1996-10-11 1997-10-08 Formulations containing phosphatidylethanolamine
AU45679/97A AU4567997A (en) 1996-10-11 1997-10-08 Formulations containing phosphatidylethanolamine
ZA9709054A ZA979054B (en) 1996-10-11 1997-10-09 Formulations containing unsaturated fatty acids.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9621293.1A GB9621293D0 (en) 1996-10-11 1996-10-11 Formulations containing unsaturated fatty acids

Publications (1)

Publication Number Publication Date
GB9621293D0 true GB9621293D0 (en) 1996-11-27

Family

ID=10801318

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9621293.1A Pending GB9621293D0 (en) 1996-10-11 1996-10-11 Formulations containing unsaturated fatty acids

Country Status (4)

Country Link
AU (1) AU4567997A (en)
GB (1) GB9621293D0 (en)
WO (1) WO1998016233A1 (en)
ZA (1) ZA979054B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19960155A1 (en) * 1999-12-14 2001-06-21 Hassia Verpackung Ag Method and device for pre-sterilizing sterile rooms on packaging machines
EP2845596A3 (en) * 2000-01-10 2015-07-15 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Use of lipid conjugates in the treatment of disease
CN114099487B (en) * 2021-12-22 2025-04-22 上海市第一人民医院 Application of ethanolamine in the preparation of products for preventing, alleviating and/or treating diseases related to neuroinflammation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212900B (en) * 1983-11-17 1989-11-30 Valle Francesco Della THERAPEUTIC USE OF PHOSPHATIDYLSERINE IN DISEASES OF THE CENTRAL NERVOUS SYSTEM WITHOUT EFFECTS ON BLOOD COAGULATION
JPS62120340A (en) * 1985-11-20 1987-06-01 Nippon Oil & Fats Co Ltd Fractionation of high unsaturated fatty acid
JPS62241510A (en) * 1986-04-14 1987-10-22 Nisshin Oil Mills Ltd:The Defoaming agent
JPS6451091A (en) * 1987-08-20 1989-02-27 Nippon Oils & Fats Co Ltd Production of diacylglycerol rich in polyfunctional unsaturated fatty acid
JPH02149588A (en) * 1988-12-01 1990-06-08 Nippon Oil & Fats Co Ltd Concentration of phosphatidylethanolamine
JP2622602B2 (en) * 1988-12-22 1997-06-18 株式会社コーセー Water-based cosmetics
JPH0344395A (en) * 1989-07-12 1991-02-26 Nippon Oil & Fats Co Ltd Preparation of powder yolk phosphatidyl ethanol amine
JPH03206891A (en) * 1990-01-05 1991-09-10 Nippon Oil & Fats Co Ltd Collection of highly unsaturated fatty acid

Also Published As

Publication number Publication date
ZA979054B (en) 1998-04-14
AU4567997A (en) 1998-05-11
WO1998016233A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
GB9301629D0 (en) Formulations containing unsaturated fatty acids
GB9710351D0 (en) Glucosamine fatty acids
ZA951661B (en) Fatty acid derivatives
GB9618420D0 (en) Fatty acid treatment
SI0823895T1 (en) Fatty acid esters as bioactive compounds
ZA963103B (en) Fatty acid derivatives
EP0801644A4 (en) Polyarylcarbamoylaza -and- carbamoylalkanedioic acids
ZA952008B (en) 5-vinyl- and 5-ethinyl-quinolene- and -naphthyridone- carboxylic acids
AU5574094A (en) Polyunsaturated fatty acyl-peptide composition
PL332553A1 (en) 3-alkooxyisooxazol-4-yl-substituted 2-aminocarboxylic acids
CY2298B1 (en) Pharmaceutical composition containing 4-oxo-butynic acids
GB9621373D0 (en) Fatty acid treatment
GB9124969D0 (en) Fatty ester hydrogenation
GB9620248D0 (en) Esters of unsaturated fatty acids
GB9621293D0 (en) Formulations containing unsaturated fatty acids
GB9805123D0 (en) Presentation of fatty acids
IL119661A0 (en) Medical use of composition comprising fatty acids
AU3645195A (en) Modified polyunsaturated fatty acids
GB2312208B (en) Preparation of carboxylic acids from alcohols
AUPM575394A0 (en) Immunostimulatory polyunsaturated fatty acids
GB9517434D0 (en) Essential fatty acid compositions
GB9618543D0 (en) Fatty acid analogues
AU3765895A (en) Synthetic polyunsaturated fatty acid analogues
GB9700383D0 (en) Fatty acid treatent
GB9828268D0 (en) Novel compounds of unsaturated fatty acids